http://rdf.ncbi.nlm.nih.gov/pubchem/patent/HR-P20080359-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f2d3599fb8f8f479dba95ca9bb504884
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-80
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-47
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-551
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-715
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-675
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-80
filingDate 2008-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_23da23cc5f6b0fd065a1d7704b76836d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7757ef2d4bf123ae90dbdd758418436c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c993519c4cc61aaa2920228e533f50eb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8ea1b420cb8f38ead140ed465124a0bc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_365d6c008ac0e8dce16ca0477eba79ba
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_733dda56f04f396e6ac5918f30573d98
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fd353bc9b009350567061c9d0ce4b4a2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d862e1070f6b798631a5f63a3fc969e5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d1b13c52d5d2891347c9170eaf8f9d55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_39c877cd5f3e3d1693817ca5555b717a
publicationDate 2016-01-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber HR-P20080359-B1
titleOfInvention PYRIMIDINES WHICH INHIBIT HIV REPLICATION
abstract The present invention relates to the use of compounds of formula (I), their N-oxides, pharmaceutically acceptable addition salts, quaternary amines and their stereochemically isomeric forms, in which the formula -a = aa = a- forms phenyl, pyridinyl, pyrimidinyl, pyridazinyl or pyrazinyl with a bonded vinyl group, n is 0 to 4, and where possible 5, R is hydrogen, aryl, formyl, C-alkyl carbonyl, C-alkyl, C-alkyloxycarbonyl, substituted C-alkyl, or substituted C-alkyloxy-C Each of R independently represents hydroxy, halogen, optionally substituted C-alkyl, C-alkenyl or C-alkynyl, C-cycloalkyl, C-alkyloxy, C-alkyloxy-carbonyl, carboxyl, cyano, nitro, amino, mono- or di- (C-alkyl) amino, polyhalomethyl, polyhalomethyloxy, polyhalomethylthio, -S (= O) R, -NH-S (= O) R, -C (= O) R, -NHC (= O) H, -C (= O) NHNH, -NHC (= O) R, -C = NH) or a five membered heterocyclic ring, p is 1 or 2, L is optionally substituted C-alkyl, C-alkenyl, C-alkynyl, C -cycloalkyl; or L is -X-R8 where R is optionally substituted phenyl, pyridinyl, pyrimidinyl, pyrazinyl or pyridazinyl, X is -NR-, -NH-NH-, -N = N-, -O-, -C (= O) -, - CHOH-, -S-, -S (= O) - or -S (= O) -; Q is hydrogen, C-alkyl, halogen, polyhalo-C-alkyl or an optionally substituted amino group; Y represents hydroxy, halogen , C-cycloalkyl, optionally substituted C-alkyl, C-alkenyl or C-alkynyl, C-alkyloxy, C-alkyloxy-carbonyl, carboxyl, cyano, nitro, amino, mono- or di (C-alkyl) amino, polyhalo -methyl, polyhalomethyloxy, polyhalomethylthio, -S (= O) R, -NH-S (= O) R, -C (= O) R, -NHC (= O) H, -C (-O) NHNH, - NHC (= O) R 1 -C (= NH) R 1 aryl, aryl is an optionally substituted phenyl, Het is an optionally substituted heterocyclic radical, for the manufacture of a medicament for the treatment of persons suffering from HIV infection (human immunodeficiency virus) .
priorityDate 1998-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9841512-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0945443-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393356
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397365
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396401
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392901
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811

Total number of triples: 51.